Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Biomesense, Inc. secured a $676,980 NIH SBIR/STTR award: Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
Amount Raised
$677,000
Round Type
Grant
ChicagoBiotechnologyInvestors
Description
The human gut microbiome is a promising avenue of precision medicine that has been linked to immunology, metabolism, neurodegenerative disease, cancer, and infectious disease. However, clinical translation of these findings has been limited. A key barrier to translation is that existing data generation tools cannot support the creation of the large, time-longitudinal datasets needed for effective discovery & reproduction of clinically actionable microbiome biomarkers. Without strong data, invest
Related People
Funding Insights
Based on industry dataWatching BiomeSense? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan